Toxic agents causing cerebellar ataxias

Handbook of Clinical Neurology

Volumn 103, Issue , 2012, Pages 201-213

  Manto, Mario ^a  

^a UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 79961134452     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-51892-7.00012-7     Document Type: Chapter

References (139)

1. Aggarwal S., Byrne B.D. Massive ischemic cerebellar infarction due to cocaine use. Neuroradiology 1991, 33:449-450.
2. Anand M., Agrawal A.K., Rehmani B.N., et al. Role of GABA receptor complex in low dose lindane (HCH) induced neurotoxicity: neurobehavioural, neurochemical and electrophysiological studies. Drug Chem Toxicol 1998, 21:35-46.
3. Anselmo M., Campos Rainho A., do Carmo Vale M., et al. Methadone intoxication in a child: toxic encephalopathy?. J Child Neurol 2006, 21:618-620.
4. Arnaud A., Neau J.P., Rivasseau-Jonveaux T., et al. Neurological toxicity of amiodarone. 5 case reports. Rev Med Interne 1992, 13:419-422.
5. Asaka T., Nitta E., Makifuchi T., et al. Germanium intoxication with sensory ataxia. J Neurol Sci 1995, 130:220-223.
6. Badhwar A., Berkovic S.F., Dowling J.P., et al. Action myoclonus-renal failure syndrome: characterization of a unique cerebro-renal disorder. Brain 2004, 127:2173-2182.
7. Bartynski W.S., Grabb B.C., Zeigler Z., et al. Watershed imaging features and clinical vascular injury in cyclosporin A neurotoxicity. J Comput Assist Tomogr 1997, 21:872-880.
8. Baulac M., Cavalcanti D., Semah F., et al. Gabapentin add-on therapy with adaptable dosages in 610 patients with partial epilepsy: an open, observational study. The French Gabapentin Collaborative Group. Seizure 1998, 7:55-62.
9. Bazille C., Megarbane B., Bensimhon D., et al. Brain damage after heat stroke. J Neuropathol Exp Neurol 2005, 64:970-975.
10. Beasley D.M., Glass W.I. Cyanide poisoning: pathophysiology and treatment recommendations. Occup Med 1998, 48:427-431.
11. Bechstein W.O. Neurotoxicity of calcineurin inhibitors: impact and clinical management. Transpl Int 2000, 13:313-326.
12. Beer T.M., Higano C.S., Saleh M., et al. Phase II study of KOS-862 in patients with metastatic androgen independent prostate cancer previously treated with docetaxel. Invest New Drugs 2007, 25:565-570.
13. Belli L.S., De Carlis L., Romani F., et al. Dysarthria and cerebellar ataxia: late occurrence of severe neurotoxicity in a liver transplant patient. Transpl Int 1993, 6:176-178.
14. Benagiano V., Lorusso L., Coluccia A., et al. Glutamic acid decarboxylase and GABA immunoreactivities in the cerebellar cortex of adult rat after prenatal exposure to a low concentration of carbon monoxide. Neuroscience 2005, 135:897-905.
15. Bonnotte B., Jolimoy C., Pacaud A., et al. Factitious hyperchloremia disclosing bromide poisoning. 4 cases. Presse Med 1997, 26:852-854.
16. Boor J.W., Hurtig H.I. Persistent cerebellar ataxia after exposure to toluene. Ann Neurol 1977, 2:440-442.
17. Brahmi N., Kouraichi N., Thabet H., et al. Influence of activated charcoal on the pharmacokinetics and the clinical features of carbamazepine poisoning. Am J Emerg Med 2006, 24:440-443.
18. Bridge T.A., Norton R.L., Robertson W.O. Pediatric carbamazepine overdoses. Pediatr Emerg Care 1994, 10:260-263.
19. Carella F., Grassi M.P., Savoiardo M., et al. Dystonic-parkinsonian syndrome after cyanide poisoning: clinical and MRI findings. J Neurol Neurosurg Psychiatry 1988, 51:1345-1348.
20. Chan M.H., Tang Y.C., Chien T.H., et al. Toluene exposure during the brain growth spurt reduced behavioural responses to nicotine in young adult rats: a potential role for nicotinic acetylcholine receptors in fetal solvent syndrome. Toxicol Sci 2008, 101:286-293.
21. Chatak N.R., Santoso R.A., McKinney W.N. Cerebellar degeneration following long-term phenytoin therapy. Neurology 1976, 26:818-820.
22. Chen W.J., Parnell S.E., West J.R. Neonatal alcohol and nicotine exposure limits brain growth and depletes cerebellar Purkinje cells. Alcohol 1998, 15:33-41.
23. Cheong R., Wilson R.K., Cortese I.C., et al. Mothball withdrawal encephalopathy: case report and review of paradichlorobenzene neurotoxicity. Subst Abus 2006, 27:63-67.
24. Clarkson T.W. The toxicology of mercury. Crit Rev Clin Lab Sci 1997, 34:369-403.
25. Damasceno B.P., de Capitani E.M. Cerebellar atrophy related to chronic exposure to toluene. Case report. Arq Neuropsiquiatr 1994, 52:90-92.
26. Daras M., Kakkouras L., Tuchman A.J., et al. Rhabdomyolysis and hyperthermia after cocaine abuse: a variant of the neuroleptic malignant syndrome?. Acta Neurol Scand 1995, 92:161-165.
27. Deutsch S.I., Mastropaolo J., Rosse R.B. Neurodevelopmental consequences of early exposure to phencyclidine and related drugs. Clin Neuropharmacol 1998, 21:320-332.
28. Dixon S.D., Bejar R. Echoencephalographic findings in neonates associated with maternal cocaine and methamphetamine use: incidence and clinical correlates. J Pediatr 1989, 115:770-778.
29. Donaldson J. The pathophysiologic significance of manganese in brain: its relation to schizophrenia and neurodegenerative disorders. Neurotoxicology 1987, 8:451-462.
30. Dorman D.C., Struve M.F., Marshall M.W., et al. Tissue manganese concentrations in young male rhesus monkeys following subchronic manganese sulfate inhalation. Toxicol Sci 2006, 92:201-210.
31. Eldridge R., Iivanainen M., Stern R., et al. 'Baltic' myoclonus epilepsy: hereditary disorder of childhood made worse by phenytoin. Lancet 1983, ii:838-842.
32. Epelman S., Nair D., Downey R., et al. Eptifibatide-induced thrombocytopenia and thrombosis. J Thromb Thrombolysis 2006, 22:151-154.
33. Finkelstein Y., Markowitz M.E., Rosen J.F. Low-level lead-induced neurotoxicity in children: an update on central nervous system effects. Brain Res Brain Res Rev 1998, 27:168-176.
34. Fonseka M.M., Medagoda K., Tillakaratna Y., et al. Self-limiting cerebellar ataxia following organophosphate poisoning. Hum Exp Toxicol 2003, 22:107-109.
35. Forrester M.B. Comparison of zolpidem and zaleplon exposures in Texas, 1998-2004. J Toxicol Environ Health 2006, 69:1883-1892.
36. Fujimoto M., Ishibashi H., Shimamura R., et al. A patient with liver cirrhosis manifesting various symptoms including cerebellar ataxia due to germanium intoxication. Fukuoka Igaku Zasshi 1992, 83:139-143.
37. Gadwalkar S.R., Bushan S., Pramod K., et al. Bilateral cerebellar infarction: a rare complication of scorpion sting. J Assoc Physicians India 2006, 54:581-583.
38. Gamelin E., Gamelin L., Bossi L., et al. Clinical aspects and molecular basis of oxaliplatin neurotoxicity: current management and development of preventive measures. Semin Oncol 2002, 29:21-33.
39. Garcia G.B., Biancardi M.E., Quiroga A.D. Vanadium-induced neurotoxicity in the rat central nervous system: a histo-immunohistochemical study. Drug Chem Toxicol 2005, 28:329-344.
40. Garretto N.S., Rey R.D., Kohler G., et al. Cerebellar syndrome caused by amiodarone. Arq Neuropsiquiatr 1994, 52:575-577.
41. Gazulla J., Tintoré M.A. The P/Q-type voltage-dependent calcium channel as pharmacological target in spinocerebellar ataxia type 6: gabapentin and pregabalin may be of therapeutic benefit. Med Hypotheses 2007, 68:131-136.
42. Gilman S., Bloedel J.R., Lechtenberg R. Disorders of the Cerebellum. Contemporary Neurology series 1981, FA Davis, Philadelphia.
43. Goasguen J., Lapresle J., Ribot C., et al. Chronic neurological syndrome resulting from intoxication with metallic uranium. Nouv Presse Med 1982, 11:119-121.
44. Gonzalez-Polo R.A., Rodriguez-Martin A., Moran J.M., et al. Paraquat-induced apoptotic cell death in cerebellar granule cells. Brain Res 2004, 1011:170-176.
45. Gordon M.F., Abrams R.I., Rubin D.B., et al. Bismuth subsalicylate toxicity as a cause of prolonged encephalopathy with myoclonus. Mov Disord 1995, 10:220-222.
46. Guilarte T.R., Chen M.K. Manganese inhibits NMDA receptor channel function: implications to psychiatric and cognitive effects. Neurotoxicology 2007, 28:1147-1152.
47. Hasan M., Ashraf I., Bajpai V.K. Electron microscopic study of the effects of thallium poisoning on the rat cerebellum. Forensic Sci 1978, 11:139-146.
48. Heaney C.J., Campeau N.G., Lindell E.P. MR imaging and diffusion-weighted imaging changes in metronidazole (Flagyl)-induced cerebellar toxicity. Am J Neuroradiol 2003, 24:1615-1617.
49. Hernández-Viadel M., Castoldi A.F., Coccini T., et al. In vivo exposure to carbon monoxide causes delayed impairment of activation of soluble guanylate cyclase by nitric oxide in rat brain cortex and cerebellum. J Neurochem 2004, 89:1157-1165.
50. Herzig R.H., Hines J.D., Herzig G.P., et al. Cerebellar toxicity with high-dose cytosine arabinoside. J Clin Oncol 1987, 5:927-932.
51. Hori A., Kazakuwa S., Fujii T., et al. Lennox-Gastaut syndrome with and without Dandy-Walker malformation. Epilepsy Res 1987, 1:258-261.
52. Houi K., Oka H., Mochio S. The effects of nicotine on a patient with spinocerebellar degeneration whose symptoms were temporarily exacerbated by cigarette smoking. Rinsho Shinkeigaku 1993, 33:774-776.
53. Ikeda M., Tsukagoshi H. Encephalopathy due to toluene sniffing. Report of a case with magnetic resonance imaging. Eur Neurol 1990, 30:347-349.
54. Ishiguro M., Yasue T., Watanabe S., et al. Efficacy of hemoperfusion in the therapy of bromvalerylurea (bromural) intoxication. J Toxicol Clin Toxicol 1982, 19:273-279.
55. Ishii K., Tamaoka A., Otsuka F., et al. Diphenylarsinic acid poisoning from chemical weapons in Kamisu, Japan. Ann Neurol 2004, 56:741-745.
56. Ishizaki M., Yanaoka T., Nakamura M., et al. Detection of phenylated arsenic compounds from the well water 2003, 43-44. Japanese Arsenic Scientist's Society, Sapporo, Japan.
57. Johnsen J.A., Miller V.T. Tobacco intolerance in multiple system atrophy. Neurology 1986, 36:986-988.
58. Johnson L.M., Hubble J.P., Koller W.C. Effect of medications and toxins on cerebellar function. Handbook of Cerebellar Diseases 1993, Marcel Dekker, New York. R. Lechtenberg (Ed.).
59. Kaleyias J., Faerber E., Kothare S.V. Tacrolimus induced subacute cerebellar ataxia. Eur J Paediatr Neurol 2006, 10:86-89.
60. Kato K., Mizoi M., An Y., et al. Oral administration of diphenylarsinic acid, a degradation product of chemical warfare agents, induces oxidative and nitrosative stress in cerebellar Purkinje cells. Life Sci 2007, 81:1518-1525.
61. Katz A.A., Hoffman R.S., Silverman R.A. Phenytoin toxicity from smoking crack cocaine adulterated with phenytoin. Ann Emerg Med 1993, 22:1485-1487.
62. Kawakami T., Takiyama Y., Yanaka I., et al. Chronic bromvalerylurea intoxication: dystonic posture and cerebellar ataxia due to nonsteroidal anti-inflammatory drug abuse. Intern Med 1998, 37:788-791.
63. King M.D. Neurological sequelae of toluene abuse. Hum Toxicol 1982, 1:281-287.
64. Klos K.J., Chandler M., Kumar N., et al. Neuropsychological profiles of manganese neurotoxicity. Eur J Neurol 2006, 13:1139-1141.
65. Korogi Y., Takahashi M., Sumi M., et al. MR imaging of Minamata disease: qualitative and quantitative analysis. Radiat Med 1994, 12:249-253.
66. Korogi Y., Takahashi M., Okajima T., et al. MR findings in Minamata disease. J Magn Reson Imaging 1998, 8:308-316.
67. Kulakowska A., Drozdowski W., Halicka D., et al. Neurologic and psychiatric sequelae of carbon monoxide poisoning. Neurol Neurochir Pol 2000, 34:587-595.
68. Kuruvilla T., Bharucha N.E. Cerebellar atrophy after acute phenytoin intoxication. Epilepsia 1997, 38:500-502.
69. Larsen A., Stoltenberg M., West M.J., et al. Influence of bismuth on the number of neurons in cerebellum and hippocampus of normal and hypoxia-exposed mouse brain: a stereological study. J Appl Toxicol 2005, 25:383-392.
70. Lawden M.C., Blunt S., Matthews T., et al. Recurrent confusion and ataxia triggered by pyrexia in a case of occult multiple sclerosis. J Neurol Neurosurg Psychiatry 1994, 57:1436.
71. Lesnik P.G., Ciesielski K.T., Hart B.L., et al. Evidence for cerebellar-frontal subsystem changes in children treated with intrathecal chemotherapy for leukemia: enhanced data analysis using an effect size model. Arch Neurol 1998, 55:1561-1568.
72. Li X., Yin J., Cheng C.M., et al. Paraquat induces selective dopaminergic nigrostriatal degeneration in aging C57BL/6 mice. Chin Med J 2005, 118:1357-1361.
73. Lodenius M., Malm O. Mercury in the Amazon. Rev Environ Contam Toxicol 1998, 157:25-52.
74. Malbrain M.L., Lambrecht G.L., Zandijk E., et al. Treatment of severe thallium intoxication. J Toxicol Clin Toxicol 1997, 35:97-100.
75. Mani J., Chaudhary N., Kanjalkar M., et al. Cerebellar ataxia due to lead encephalopathy in an adult. J Neurol Neurosurg Psychiatry 1998, 65:797.
76. Manto M., Godaux E., Jacquy J., et al. Analysis of cerebellar dysmetria associated with lithium intoxication. Neurol Res 1996, 18:416-424.
77. Manto M.U., Jacquy J. Other cerebellotoxic agents. The Cerebellum and its Disorders 2002, 342-366. Cambridge University Press, Cambridge. M.U. Manto, M. Pandolfo (Eds.).
78. Manto M.U., Topka H. Reversible cerebellar gait ataxia with postural tremor during episodes of high pyrexia. Clin Neurol Neurosurg 1996, 98:227-230.
79. Mascalchi M., Petruzzi P., Zampa V. MRI of cerebellar white matter damage due to carbon monoxide poisoning: case report. Neuroradiology 1996, 38:73-74.
80. Masland R.L. Carbamazepine neurotoxicity. Antiepileptic Drugs 1982, 521-531. Raven Press, New York. 2nd edn. D.M. Woodbury, J.K. Penry, C.E. Pippenger (Eds.).
81. Masur H., Elger C.E., Ludolph A.C., et al. Cerebellar atrophy following acute intoxication with phenytoin. Neurology 1989, 39:432-433.
82. Meggs W.J., Cahill-Morasco R., Shih R.D., et al. Effects of Prussian blue and N-acetylcysteine on thallium toxicity in mice. J Toxicol Clin Toxicol 1997, 35:163-166.
83. Mills F., MacLennan S.C., Devile C.J., et al. Severe cerebellitis following methadone poisoning. Pediatr Radiol 2008, 38:227-229.
84. Moertel C.G., Reitemeier R.J., Bolton C.E., et al. Cerebellar ataxia associated with fluorinated pyrimidine therapy. Cancer Chemother Rep 1964, 41:15-18.
85. Mohapatro A.K., Thomas M., Jain S., et al. Pancerebellar syndrome in hyperpyrexia. Australas Radiol 1990, 34:320-322.
86. Monyer H., Burnashev N., Laurie D.J., et al. Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 1994, 12:529-540.
87. Mourre C., Widmann C., Lazdunski M. Saxitoxin-sensitive Na+ channels: presynaptic localization in cerebellum and hippocampus of neurological mutant mice. Brain Res 1990, 533:196-202.
88. Nick J., Dudognon P., Escourolle R., et al. Neurological disorders and perhexiline maleate therapy. Clinical study of 10 cases. Neuropathological, pharmacokinetic and biochemical studies. Rev Neurol (Paris) 1978, 134:103-114.
89. Niemann B., Rochlitz C., Herrmann R., et al. Toxic encephalopathy induced by capecitabine. Oncology 2004, 66:331-335.
90. Ninomiya T., Ohmori H., Hashimoto K., et al. Expansion of methylmercury poisoning outside of Minamata: an epidemiological study on chronic methylmercury poisoning outside of Minamata. Environ Res 1995, 70:47-50.
91. Nussbaum E.S., Maxwell R.E., Bitterman P.B., et al. Cyclosporine A toxicity presenting with acute cerebellar edema and brainstem compression. Case report. J Neurosurg 1995, 82:1068-1070.
92. O'Donnell P., Buxton P.J., Pitkin A., et al. The magnetic resonance imaging appearances of the brain in acute carbon monoxide poisoning. Clin Radiol 2000, 55:273-280.
93. Oehmichen M., Meissner C., Reiter A., et al. Neuropathology in non-human immunodeficiency virus-infected drug-addicts: hypoxic brain damage after chronic intravenous drug abuse. Acta Neuropathol 1996, 91:642-646.
94. Pahwa R. Toxin-induced parkinsonian syndromes. Movement Disorders 1997, 315-323. McGraw-Hill, New York. R.L. Watts, W.C. Koller (Eds.).
95. Palmer B.F., Toto R.D. Severe neurologic toxicity induced by cyclosporine A in three renal transplant patients. Am J Kidney Dis 1991, 1:116-121.
96. Pappas C.L., Quisling R.G., Ballinger W.E., et al. Lead encephalopathy: symptoms of a cerebellar mass lesion and obstructive hydrocephalus. Surg Neurol 1986, 26:391-394.
97. Parakh S., Naik N., Rohatgi N., et al. Eptifibatide overdose. Int J Cardiol 2009, 131:430-432.
98. Pardal P.P., Castro L.C., Jennings E., et al. Epidemiological and clinical aspects of scorpion envenomation in the region of Santarem, Para, Brazil. Rev Soc Bras Med Trop 2003, 36:349-353.
99. Pearson G.S., Magee R.S. Critical evaluation of proven chemical weapon destruction technologies. Pur Appl Chem 2002, 74:187-316.
100. Playford R.J., Matthews C.H., Campbell M.J., et al. Bismuth induced encephalopathy caused by tri potassium dicitrato bismuthate in a patient with chronic renal failure. Gut 1990, 31:359-360.
101. Rangi P.S., Partridge W.J., Newlands E.S., et al. Posterior reversible encephalopathy syndrome: a possible late interaction between cytotoxic agents and general anaesthesia. Neuroradiology 2005, 47:586-590.
102. Rhodes F.A., Mills C.G., Popei K. Paralytic shellfish poisoning in Papua New Guinea. P N G Med J 1975, 18:197-202.
103. Rittmannsberger H., Lebhuler F. Asterixis induced by carbamazepine. Biol Psychiatry 1992, 32:364-368.
104. Roegge C.S., Schantz S.L. Motor function following developmental exposure to PCBs and/or MeHg. Neurotoxicol Teratol 2006, 28:260-277.
105. Rosenow F., Herholz K., Lanfermann H., et al. Neurological sequelae of cyanide intoxication - the patterns of clinical, magnetic resonance imaging, and positron emission tomography findings. Ann Neurol 1995, 38:825-828.
106. Rothner A.D., Pippenger C., Cruse R.P., et al. Carbamazepine toxicity with therapeutic total levels and elevated free levels. Ann Neurol 1987, 22:413-414.
107. Ryan A., Molloy F.M., Farrell M.A., et al. Fatal toxic leukoencephalopathy: clinical, radiological, and necropsy findings in two patients. J Neurol Neurosurg Psychiatry 2005, 76:1014-1016.
108. Sabbioni E., Manzo L. Metabolism and toxicity of thallium. Advances in Neurotoxicology 1980, 249-270. Pergamon Press, Oxford. L. Manzo (Ed.).
109. Saito K., Wada H. Behavioral approaches to toluene intoxication. Environ Res 1993, 62:53-62.
110. Savoldi F., Mazzella G.L., Bo P., et al. Cerebellar ataxia due to acute carbon monoxide poisoning. Riv Neurobiol 1973, 19:197-206.
111. Schwartz A.B., Klausner S.C., Yee S., et al. Cerebellar ataxia due to procainamide toxicity. Arch Intern Med 1984, 144:2260-2261.
112. Schwartz R.H., Einhorn A. PCP intoxication in seven young children. Pediatr Emerg Care 1986, 2:238-241.
113. Sein Anand J., Chodorowski Z., Hadjuk A. Acute intoxication with zaleplon - a case report. Przegl Lek 2007, 64:310-311.
114. Selhorst J.B., Kaufman B., Horwitz S.J. Diphenylhydantoin-induced cerebellar degeneration. Arch Neurol 1972, 27:452-455.
115. Shimizu K., Matsubara K., Ohtaki K., et al. Paraquat induces long-lasting dopamine overflow through the excitotoxic pathway in the striatum of freely moving rats. Brain Res 2003, 976:243-252.
116. Shimizu K., Ohtaki K., Matsubara K., et al. Carrier-mediated processes in blood-brain barrier penetration and neural uptake of paraquat. Brain Res 2001, 906:135-142.
117. Simard M., Gumbiner B., Lee A., et al. Lithium carbonate intoxication. A case report and review of the literature. Arch Intern Med 1989, 149:36-46.
118. Singh Y.N., Singh N.N. Therapeutic potential of kava in the treatment of anxiety disorders. CNS Drugs 2002, 16:731-743.
119. Specht U., May T.W., Rohde M., et al. Cerebellar atrophy decreases the threshold of carbamazepine toxicity in patients with chronic focal epilepsy. Arch Neurol 1997, 54:427-431.
120. Experimental and Clinical Neurotoxicology 1980, Williams and Wilkins, Baltimore. P.S. Spencer, H.H. Schaumburg (Eds.).
121. Sperling R.T., Pinto D.S., Ho K.K., et al. Platelet glycoprotein IIb/IIIa inhibition with eptifibatide: prolongation of inhibition of aggregation in acute renal failure and reversal with hemodialysis. Catheter Cardiovasc Interv 2003, 59:459-462.
122. Squier W., Hope P.L., Lindenbaum R.H. Neocerebellar hypoplasia in a neonate following intra-uterine exposure to anti-convulsants. Dev Med Child Neurol 1990, 32:737-742.
123. Stelmashook E.V., Isaev N.K., Zorov D.B. Paraquat potentiates glutamate toxicity in immature cultures of cerebellar granule neurons. Toxicol Lett 2007, 174:82-88.
124. Stengard K., Tham R., O'Connor W.T., et al. Acute toluene exposure increases extra-cellular GABA in the cerebellum of rat: a microdialysis study. Pharmacol Toxicol 1993, 73:315-318.
125. Takahashi M., Aki T., Yasuhara M., et al. Apoptotic and necrotic brain lesions in a fatal case of carbon monoxide poisoning. Forensic Sci Int 2001, 116:213-219.
126. Tarben T., Cominos B., Lee C.T. Topical eucalyptus oil poisoning. Australas J Dermatol 1998, 39:265-267.
127. Thompson C.B., June C.H., Sullivan K.M., et al. Association between cyclosporin neurotoxicity and hypomagnesemia. Lancet 1984, ii:1116-1120.
128. Tibballs J. Clinical effects and management of eucalyptus oil ingestion in infants and young children. Med J Aust 1995, 163:177-180.
129. Tripathi S.K., Pandey S.K. The effect of aluminium phosphide on the human brain: a histological study. Med Sci Law 2007, 47:141-146.
130. Turpin J.C., Pluot M., Albouz S., et al. Study of thesaurismosis induced by perhexiline maleate. Confirmation of experimental data. Sem Hop 1983, 59:58-61.
131. Uchino A., Kato A., Yuzuriha T., et al. Comparison between patient characteristics and cranial MR findings in chronic thinner intoxication. Eur Radiol 2002, 12:1338-1341.
132. Vergauwe P.L., Knockaert D.C., Van Tittelbaum T.J. Near fatal subacute thallium poisoning necessitating prolonged mechanical ventilation. Am J Emerg Med 1990, 8:548-550.
133. Wainwright A.P., Kox W.J., House I.M., et al. Clinical features and therapy of acute thallium poisoning. Q J Med 1988, 69:939-944.
134. Weber W., Henkes H., Moller P., et al. Toxic spongiform leucoencephalopathy after inhaling heroin vapour. Eur Radiol 1998, 8:749-755.
135. Wizniter M., Packer R.J., Rorke L.B., et al. Cerebellar sclerosis in pediatric cancer patients. J Neurooncol 1987, 4:353-360.
136. Yamanouchi N., Okada S., Kodama K., et al. White matter changes caused by chronic solvent abuse. Am J Neuroradiol 1995, 16:1643-1649.
137. Yaqhb B., Al Deeb S. Heat strokes: aetiopathogenesis, neurological characteristics, treatment and outcome. J Neurol Sci 1998, 156:144-151.
138. Yokoyama K., Araki S., Murata K., et al. Subclinical vestibulo-cerebellar, anterior cerebellar lobe and spinocerebellar effects in lead workers in relation to concurrent and past exposure. Neurotoxicology 1997, 18:371-380.
139. Zitelli B.J., Howrie D.L., Altman H., et al. Erythromycin-induced drug interactions. An illustrative case and review of the literature. Clin Pediatr 1987, 26:117-119.